Cargando…
Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
Cytokine signaling, especially interferon (IFN) signaling is closely linked to several aspects of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. During initial SARS‐CoV‐2 infection, symptomatic patients present with impaired type I/III IFN‐mediated antiviral responses. Inter...
Autores principales: | Solimani, Farzan, Meier, Katharina, Ghoreschi, Kamran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250126/ https://www.ncbi.nlm.nih.gov/pubmed/33675065 http://dx.doi.org/10.1002/eji.202149173 |
Ejemplares similares
-
Emerging Topical and Systemic JAK Inhibitors in Dermatology
por: Solimani, Farzan, et al.
Publicado: (2019) -
Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris
por: Meier, Katharina, et al.
Publicado: (2020) -
Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
por: Ogger, Patricia P., et al.
Publicado: (2022) -
A promiscuous interaction of SARS-CoV-2 with bacterial products
por: Carissimo, Guillaume, et al.
Publicado: (2020) -
Virtual Issue on SARS-CoV-2: Evolution of a Pandemic
por: McGrath, Casey
Publicado: (2023)